Lucas Opazo-Ríos

Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease

Manuel Soto‐Catalán, Lucas Opazo-Ríos, Hernán Quiceno et al. · International Journal of Molecular Sciences · 2024 · 37 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes

Lucas Opazo-Ríos, Yenniffer Sánchez Matus, Raúl R. Rodrigues-Díez et al. · BMJ Open Diabetes Research & Care · 2020 · 25 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy

Lucas Opazo-Ríos, Anita Plaza, Yenniffer Sánchez Matus et al. · International Journal of Molecular Sciences · 2020 · 17 citations · Full text

Medicine, Molecular Biology, Nephrology +17

Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

Lucas Opazo-Ríos, Antonio Tejera‐Muñoz, Manuel Soto‐Catalán et al. · Frontiers in Pharmacology · 2022 · 15 citations · Full text

Medicine, Molecular Biology, Pathobiology +17

Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury

Cristina Vázquez‐Carballo, Carmen Herencia, Melania Guerrero‐Hue et al. · The Journal of Pathology · 2022 · 15 citations · Full text

Medicine, Immunology, Pathobiology +16